KOPRAN
Small Cap BSE: 524280 NSE: KOPRAN
₹160.35
-2.7 (-1.66%)
As on 01 December, 2022 | 05:05

Kopran Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in KOPRAN

Start SIP

Kopran Share Price

Kopran Share Returns

  • Over 1 Month -10.02%
  • Over 3 Month -13.74%
  • Over 6 Month -27.66%
  • Over 1 Year -36.08%

Kopran Key Statistics

P/E Ratio 15.5
PEG Ratio -1.9
Market Cap Cr 773
Price to Book Ratio 1.8
EPS 2.4
Dividend 1.9
Relative Strength Index 47.14
Money Flow Index 69.36
MACD Signal -2.45
Average True Range 9.48

Kopran Investment Rating

  • Master Rating:
  • Kopran has an operating revenue of Rs. 512.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kopran Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 54706455562962
Operating Expenses Qtr Cr 48645851522955
Operating Profit Qtr Cr 6673517
Depreciation Qtr Cr 1111111
Interest Qtr Cr 1011111
Tax Qtr Cr 1121102
Net Profit Qtr Cr 18452416

Kopran Technicals

EMA & SMA

Current Price
160.35
-2.7 (-1.66%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 162.98
  • 50 Day
  • 167.91
  • 100 Day
  • 182.65
  • 200 Day
  • 217.14
  • 20 Day
  • 163.76
  • 50 Day
  • 164.42
  • 100 Day
  • 178.69
  • 200 Day
  • 217.01

Kopran Resistance and Support

PIVOT
₹164.64
Resistance
First Resistance 167.62
Second Resistance 172.19
Third Resistance 175.17
RSI 47.14
MFI 69.36
MACD Single Line -2.45
MACD -1.67
Support
First Resistance 160.07
Second Resistance 157.09
Third Resistance 152.52

Kopran Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 77,440 4,840,000 62.5
Week 246,006 9,840,232 40
1 Month 350,438 13,236,027 37.77
6 Month 165,414 7,661,965 46.32

Kopran Result Highlights

Kopran Synopsis

NSE-Medical-Diversified

Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 204.52 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2022. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.
Market Cap 773
Sales 243
Shares in Float 2.70
No of funds 17
Yield 1.87
Book Value 2.04
U/D Vol ratio 1.7
LTDebt / Equity 1
Alpha -0.19
Beta 1.28

Kopran

Owner NameSep-22Jun-22Mar-22Jan-22
Promoters 44.25%44.25%44.25%
Mutual Funds
Insurance Companies 0.14%0.14%0.14%
Foreign Portfolio Investors 0.51%0.5%0.53%
Financial Institutions/ Banks
Individual Investors 39.53%39.89%39.78%
Others 15.57%15.22%15.3%

Kopran Management

Name Designation
Mr. Susheel G Somani Chairman
Mr. Surendra Somani Executive Vice Chairman
Mr. Adarsh Somani Director
Mr. Varun Somani Director
Dr. Siddhan Subramanian Independent Director
Dr. Sunita Banerji Independent Director
Mrs. Mamta Biyani Independent Director
Mr. Narayan Atal Independent Director

Kopran Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kopran Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results
2022-08-10 Quarterly Results
2022-05-27 Audited Results & Final Dividend
2022-02-03 Quarterly Results
2021-10-27 Quarterly Results

Kopran MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Kopran FAQs

What is Share Price of Kopran ?

Kopran share price is ₹160 As on 01 December, 2022 | 04:51

What is the Market Cap of Kopran ?

The Market Cap of Kopran is ₹773.1 Cr As on 01 December, 2022 | 04:51

What is the P/E ratio of Kopran ?

The P/E ratio of Kopran is 15.5 As on 01 December, 2022 | 04:51

What is the PB ratio of Kopran ?

The PB ratio of Kopran is 1.8 As on 01 December, 2022 | 04:51

Q2FY23